Results 301 to 310 of about 460,443 (348)

Kidney Fibrosis In Vitro and In Vivo Models: Path Toward Physiologically Relevant Humanized Models

open access: yesAdvanced Healthcare Materials, Volume 14, Issue 9, April 4, 2025.
This review discusses kidney diseases with a focus on kidney fibrosis and the models currently used. It highlights the limitations of animal and 2D in vitro models in replicating human kidney anatomy and physiology. Consequently, there is a significant need for humanized 3D in vitro models, such as 3D cell aggregates, membranes and hydrogels, on‐chip ...
Gabriele Addario   +2 more
wiley   +1 more source

Novel Less Toxic, Lymphoid Tissue‐Targeted Lipid Nanoparticles Containing a Vitamin B5‐Derived Ionizable Lipid for mRNA Vaccine Delivery

open access: yesAdvanced Healthcare Materials, Volume 14, Issue 7, March 14, 2025.
The top‐performing lipid nanoparticle, incorporating a novel ionizable lipid derived from vitamin B5, demonstrates high mRNA transfection efficiency, low toxicity, favorable stability, targeted delivery to lymphoid tissues, and high immunogenicity, showing promise as a carrier for mRNA vaccines for infectious diseases and cancer.
Soyeon Yoo   +11 more
wiley   +1 more source

Analysis and interpretation of inflammatory fluid markers in Alzheimer's disease: a roadmap for standardization. [PDF]

open access: yesJ Neuroinflammation
Bettcher BM   +10 more
europepmc   +1 more source

Salt‐Compact Albumin as a New Pure Protein‐based Biomaterials: From Design to In Vivo Studies

open access: yesAdvanced Healthcare Materials, Volume 14, Issue 7, March 14, 2025.
A new class of materials built entirely of native albumin protein is designed using a simple protocol based on salt‐assisted compaction, breaking with current crosslinking strategies. This green process leads, surprisingly, to water‐insoluble handable materials with high preservation of their native protein structures and Young's modulus close to that ...
Eya Aloui   +19 more
wiley   +1 more source

The role of IL-6 in thyroid eye disease: an update on emerging treatments. [PDF]

open access: yesFront Ophthalmol (Lausanne)
Murdock J   +8 more
europepmc   +1 more source

Pincer‐Type Pt(II)‐NHC Antibody‐Drug Conjugate for HER‐2‐Targeted Chemoimmunotherapy

open access: yesAdvanced Healthcare Materials, Volume 14, Issue 9, April 4, 2025.
The antibody‐drug conjugate Trastuzumab‐Pt1 has demonstrated successful development as a targeted therapeutic strategy for human epidermal growth factor receptor (HER‐2) high‐expression tumors. This innovative approach enables the efficient delivery of the cytotoxic payload Pt‐1 to mitochondria, thereby synergistically inducing necroptosis and ...
Tao Huang   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy